Blocking Type I Interferon Production: A New Therapeutic Option to Reduce the HIV-1-Induced Immune Activation

by Moritz Ries, Kathrin Pritschet, Barbara Schmidt
Published 2012-01-01

Chronic immune activation in HIV-1 infection contributes to reduced interferon alpha production via enhanced CD40:CD40 ligand interaction.

by Norbert Donhauser, Kathrin Pritschet, Martin Helm, Thomas Harrer, Philipp Schuster, Moritz Ries, Georg Bischof, Jörg Vollmer, Sigrun Smola, Barbara Schmidt, German Competence Network HIV/AIDS
Published 2012-01-01